Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Blood clotting and stroke drug approved

  • Comment

Blood clotting and strokes could be prevented by a new medicine that has been given the green light for use by the NHS in Scotland.

Blood-thinning drug Pradaxa is taken by adults who suffer from atrial fibrilation.

Tests by the Scottish Medicines Consortium (SMC) found that it had the same success levels as Warfarin, which is also used to protect against strokes.

Different side effects are associated with the two alternative medicines. Unlike Pradaxa, an increased risk of major bleeding is associated with Warfarin, but dyspepsia is more common in those who take Pradaxa as opposed to Warfarin.

The SMC said that it gave Pradaxa its approval because it is effective and provides reasonable value for money. Also, nurses are not required to monitor patients’ blood after they have received the drug.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.